Randomized controlled trials (RCTs) examining continuous (CS) versus intermittent strategies (IS) of delivering systemic treatment (Tx) for untreated metastatic colorectal cancer (mCRC): An updated meta-analysis from the Cancer Care Ontario program in evidence-based care.

Scott R Berry,Timothy R Asmis,Nazik Hammad,Roxanne Cosby,Monika K Krzyzanowska,Kelvin K Chan

doi:10.1200/jco.2014.32.15_suppl.3567

Randomized controlled trials (RCTs) examining continuous (CS) versus intermittent strategies (IS) of delivering systemic treatment (Tx) for untreated metastatic colorectal cancer (mCRC): An updated meta-analysis from the Cancer Care Ontario program in evidence-based care.

Scott R Berry, Timothy R Asmis + Show 4 more

https://doi.org/10.1200/jco.2014.32.15_suppl.3567

Copy DOI

Export

Save

Cite

Journal: Journal of Clinical Oncology

Publication Date: May 20, 2014

Affiliation: Sunnybrook Health Science Centre, University of Toronto, Ottawa Hospital Research Institute, Cancer Care South East, McMaster University, Princess Margaret Cancer Centre

#Program In Evidence-based Care #Continuous #Intermittent Strategies #Systemic Treatment For Cancer #Updated Meta-analysis #Treatment For Metastatic Colorectal Cancer #Evidence-based Care #Randomized Controlled Trials #Treatment For Colorectal Cancer #Untreated Cancer

Abstract
Full-Text
Similar Papers

Abstract

Listen

Randomized controlled trials (RCTs) examining continuous (CS) versus intermittent strategies (IS) of delivering systemic treatment (Tx) for untreated metastatic colorectal cancer (mCRC): An updated meta-analysis from the Cancer Care Ontario program in evidence-based care.

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of Clinical Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Randomized controlled trials (RCTs) examining continuous (CS) versus intermittent strategies (IS) of delivering systemic treatment (Tx) for untreated metastatic colorectal cancer (mCRC): An updated meta-analysis from the Cancer Care Ontario program in evidence-based care.